House socialists' new drug plan: Straight from Atlas Shrugged

[bripat9643]

Now that's a guaranteed way to get drug companies lining up to spend $500 million on the development of new drugs.

https://www.americanthinker.com/blo...w_drug_plan_straight_from_atlas_shrugged.html​

Now, here's The Nation breathlessly describing the House socialists' new plan: the bill, Richard Eskow writes, "has the potential to start a new national conversation about the federal government’s relationship to intellectual property, monopoly power, and human needs." The gist is this: if an unelected government official decides there is sufficient need, the patent for a new drug can be voided.​

 

[Moonglow]

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

 

[danielpalos]

Now that's a guaranteed way to get drug companies lining up to spend $500 million on the development of new drugs.

https://www.americanthinker.com/blo...w_drug_plan_straight_from_atlas_shrugged.html​

Now, here's The Nation breathlessly describing the House socialists' new plan: the bill, Richard Eskow writes, "has the potential to start a new national conversation about the federal government’s relationship to intellectual property, monopoly power, and human needs." The gist is this: if an unelected government official decides there is sufficient need, the patent for a new drug can be voided.​

An public policy constitutes an public use; eminent domain applies.

 

[Norman]

The plan how to not have cancer cure in the next 1000 years.

 

[bripat9643]

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

 

[Moonglow]

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

Do you enjoy seeing people that need meds having to be jacked, gouged or taken out of price range for affordability over market exclusivity? Or should meds be used for the betterment of the person that needs such drug?

 

[bripat9643]

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

Do you enjoy seeing people that need meds having to be jacked, gouged or taken out of price range for affordability over market exclusivity? Or should meds be used for the betterment of the person that needs such drug?

If drug companies can't make a profit on what they produce, there won't be any meds, you dumb ****.

First you denied the bill did what I claimed, and then you tried to justify theft.

 

[sartre play]

Have you checked the profits drug company's are making of late?

 

[bripat9643]

Have you checked the profits drug company's are making of late?

I think we all know what would happen if the government expropriated drug company profits.

 

[jon_berzerk]

The plan how to not have cancer cure in the next 1000 years.

nope not true

anyone who thinks "they" have a cure for cancer and choose not to do it

or dont want to find the "cure"

is just blatantly ignorant about the disease

there are literally hundreds and hundreds of different types of cancer

there has been remarkable success with many of them

 

[Fort Fun Indiana]

I suggest you read the actual bill and not the biased story from American Stinker...

And for sure he never read the book....

 

[danielpalos]

Have you checked the profits drug company's are making of late?

care to cite some anecdotes.

 

[covertrain]

Let me sum up. Blah blah blah...Libertards.....blah blah blah.... socialists coming to get us all.....blah blah blah...Libertards.....MAGA!


There. Saved everyone time. You’re welcome!

 

[danielpalos]

some drugs truly can promote the general welfare; why not purchase the patent through eminent domain to hasten research into more generic drugs.

 

[Moonglow]

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

Do you enjoy seeing people that need meds having to be jacked, gouged or taken out of price range for affordability over market exclusivity? Or should meds be used for the betterment of the person that needs such drug?

If drug companies can't make a profit on what they produce, there won't be any meds, you dumb ****.

First you denied the bill did what I claimed, and then you tried to justify theft.

I never denied the bill and even posted part of the language in the bill...Try to create an enemy out of someone else.

 

[bripat9643]

To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of prescription drugs furnished under part D of the Medicare program.

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

Do you enjoy seeing people that need meds having to be jacked, gouged or taken out of price range for affordability over market exclusivity? Or should meds be used for the betterment of the person that needs such drug?

If drug companies can't make a profit on what they produce, there won't be any meds, you dumb ****.

First you denied the bill did what I claimed, and then you tried to justify theft.

I never denied the bill and even posted part of the language in the bill...Try to create an enemy out of someone else.

Of course you were denying that it revoked drug patents.

Who do you think you're fooling?

 

[Moonglow]

This is what the bill itself states.

Text - H.R.6505 - 115th Congress (2017-2018): Medicare Negotiation and Competitive Licensing Act of 2018

I suggest you read the actual bill and not the biased story from American Stinker...

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

Do you enjoy seeing people that need meds having to be jacked, gouged or taken out of price range for affordability over market exclusivity? Or should meds be used for the betterment of the person that needs such drug?

If drug companies can't make a profit on what they produce, there won't be any meds, you dumb ****.

First you denied the bill did what I claimed, and then you tried to justify theft.

I never denied the bill and even posted part of the language in the bill...Try to create an enemy out of someone else.

Of course you were denying that it revoked drug patents.

Who do you think you're fooling?

Do you normally mentally masturbate online...If the benefit is more inclined to favor the patient over profits why not?

 

[bripat9643]

Here ya go, turd, the part that says the government can revoke a company's patent:

“(A) IN GENERAL.—Notwithstanding any exclusivity under clause (iii) or (iv) of section 505(j)(5)(F) of the Federal Food, Drug, and Cosmetic Act, clause (iii)or (iv) of section 505(c)(3)(E) of such Act, section 351(k)(7)(A) of the Public Health Service Act, or section 527(a) of the Federal Food, Drug, and Cosmetic Act, or by an extension of such exclusivity under section 505A of such Act or section 505E of such Act, and any other provision of law that provides for market exclusivity (or extension of market exclusivity) with respect to a drug, in the case that the Secretary is unable to successfully negotiate an appropriate price for a covered part D drug for a negotiated price period, the Secretary shall authorize the use of any patent, clinical trial data, or other exclusivity granted by the Federal government with respect to such drug as the Secretary determines appropriate for purposes of manufacturing such drug for sale under a prescription drug plan or MA–PD plan. Any entity making use of a competitive license to use patent, clinical trial data, or other exclusivity under this section shall provide to the manufacturer holding such exclusivity reasonable compensation, as determined by the Secretary based on the following factors:

“(i) The risk-adjusted value of any Federal government subsidies and investments in research and development used to support the development of such drug.

“(ii) The risk-adjusted value of any investment made by such manufacturer in the research and development of such drug.

“(iii) The impact of the price, including license compensation payments, on meeting the medical need of all patients.

“(iv) The relationship between the price of such drug, including compensation payments, and the health benefits of such drug.

“(v) Other relevant factors determined appropriate by the Secretary to provide reasonable compensation.​

Do you enjoy seeing people that need meds having to be jacked, gouged or taken out of price range for affordability over market exclusivity? Or should meds be used for the betterment of the person that needs such drug?

If drug companies can't make a profit on what they produce, there won't be any meds, you dumb ****.

First you denied the bill did what I claimed, and then you tried to justify theft.

I never denied the bill and even posted part of the language in the bill...Try to create an enemy out of someone else.

Of course you were denying that it revoked drug patents.

Who do you think you're fooling?

Do you normally mentally masturbate online...If the benefit is more inclined to favor the patient over profits why not?

ROFL! In the short run. In the long run it means numerous miracle drugs will never come to market because the drug companies will rightly conclude that the government will expropriate their patents. The most beneficial drugs will be the ones most likely never to get to market. The drugs that prevent aging or cure cancer will never be invented.

You are the poster child for "stupid, short sighted snowflake."

 

[Fort Fun Indiana]

In the long run it means numerous miracle drugs will never come to market because the drug companies will rightly conclude that the government will expropriate their patents.

Which means they will get paid.

 

[bripat9643]

In the long run it means numerous miracle drugs will never come to market because the drug companies will rightly conclude that the government will expropriate their patents.

Which means they will get paid.

It means exactly the opposite, dumbass.